Announcements Trials
Browse Landscape

Phase

Phase 3 10Phase 2 8Phase NA 3Phase 1/2 3Phase 4 2Phase 2/3 1Phase 1 1

Status

Completed 19Unknown 3Terminated 3Recruiting 2Active not recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Genitourinary 1

Conditions

Prostatic Neoplasms 1Lymphoma 1Hodgkin Disease 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 27Cisplatin 27Carboplatin 27Capecitabine 27camrelizumab 24Nivolumab 23apatinib 22Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 17Immunotherapy, Adoptive 17Drug Therapy 17pembrolizumab 16Docetaxel 16Dexamethasone 15Bevacizumab 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12130-nm albumin-bound paclitaxel 11anlotinib 10Fluorouracil 10Trastuzumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Mitoxantrone × Clear all
NCT03576378 2024-02-26

BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Phase 1/2 Unknown
41 enrolled
Lymphoid

Hodgkin Disease

NCT00003183 2013-12-04

Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
64 enrolled
Genitourinary

Prostatic Neoplasms

NCT00032149 2013-09-20

Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡